Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Release

Reuters
Feb 05
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Release

Haemonetics Corporation announced the availability of its Third Quarter Fiscal 2026 Earnings Release, covering the period ended December 27, 2025. The financial release and a supplemental earnings presentation have been posted on the company's Investor Relations website at www.haemonetics.com. The following materials are available: - Third Quarter Fiscal 2026 Earnings Release - Third Quarter Fiscal 2026 Supplemental Earnings Presentation A conference call and webcast to discuss the results will be held at 8:00 a.m. ET on February 5, 2026. Registration for the call is available at Click here to register. A live webcast can be accessed at Access here or via the Investor Relations section of the Haemonetics website. A replay will be available beginning at 11:00 a.m. ET on February 5, 2026, and will remain accessible for one year via the webcast link.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NE78738) on February 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10